iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Glenmark Pharmaceuticals Receives USFDA Nod for Generic Mental Disorder Treatment

7 Nov 2023 , 10:55 AM

Glenmark Pharmaceuticals Ltd has received final approval from the US Food & Drug Administration (US FDA) for its generic Fluphenazine Hydrochloride tablets used in the treatment of specific mental disorders.

The approval covers Fluphenazine Hydrochloride tablets with strengths of 1 mg, 2.5 mg, 5 mg, and 10 mg, according to a statement from Glenmark. These generic tablets are equivalent to Prolixin tablets of the same strengths produced by Apothecon Inc.

Glenmark Pharmaceuticals Inc, USA, will be responsible for distributing the company’s Fluphenazine Hydrochloride tablets in the United States.

Prolixin tablets, in strengths matching those of Glenmark’s generic versions, achieved approximately USD 18.1 million in annual sales for the 12 months ending in September 2023, based on IQVIA data cited by Glenmark.

For feedback and suggestions, write to us at editorial@iifl.com

 

Related Tags

  • Glenmark Pharmaceuticals
  • Pharma
  • pharmaceuticals
  • USFDA
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.